Use of spiro-oxindole compounds as therapeutic agents
US8466188B2 · kind B2 · utility
28Cited by
47References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2007 |
| Grant date | Jun 18, 2013 |
| Priority date | — |
| Expiry date | Jul 21, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment and/or prevention of hypercholesterolemia, benign prostatic hyperplasia, pruritis and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.